Chemokines are a group of small molecular weight proteins that are structurally related.
These molecules play an important role in the growth, differentiation and activation of many …

Inflammation might substantially contribute to the limited therapeutic success of current
systemic therapies in colorectal cancer (CRC). Amongst cytokines involved in CRC biology …

Background & aims Chronic inflammation is a leading cause of colorectal cancer (CRC).
Inflammatory biomarkers are considered indicators of occult malignancy. To contribute to the …

Introduction CRC with liver metastases is a major contributor to cancer-related mortality.
Despite advancements in liver resection techniques, patient survival remains a concern due …

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide, being the
third most commonly diagnosed malignancy and the second leading cause of cancer …

Background The inflammatory potential of the diet has been associated with colorectal
cancer (CRC) risk, but its association with CRC prognosis is unclear. Objective To …

The prediction of colorectal cancer (CRC) response to palliative chemotherapy (CTH) is still
difficult. Patients at a higher risk of progression may benefit from more aggressive treatment …

Cancer cachexia remains a serious public health concern worldwide, particularly as cancer
rates rise. Treatment is endangered, and survival is reduced, because this illness is …

Aim. To study the expression of angiodrastic chemokines in colorectal tumors and correlate
findings with clinicopathological parameters and survival. Methods. The proangiogenic …

Despite treatment of patients with metastatic colorectal cancer (mCRC) with bevacizumab
plus chemotherapy, response rates are modest and there are no biomarkers available that …